SCHEMBL5147463

SCHEMBL5147463

O=C1NC(=O)/C(=C(\Cc2ccc(F)cc2)c2ccc(-c3cc(C(=O)O)ccc3Cl)o2)N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
POLB P06746 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 4/20 0.40
APEX1 P27695 1/20 0.40
APOBEC3A P31941 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
PKM P14618 2/20 0.39
STAT3 P40763 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SLC1A3 P43003 3/20 0.37
MAPT P10636 2/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
S1PR4 O95977 1/20 0.35
ITGB2 P05107 1/20 0.34
ITGAM P11215 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147466 1.00 MEN1 (0.44) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL5145012 0.87 MEN1 (0.42) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL5145398 0.84 ENPP2 (0.43) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL5146594 0.83 ALDH1A1 (0.55) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL14426477 0.70 KMT2A (0.68) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL6393742 0.69 TDP1 (0.79) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL6393226 0.69 TDP1 (0.79) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL5143420 0.65 PIM1 (0.46) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL14291459 0.64 MEN1 (0.69) MEN1KMT2APOLBTDP1L3MBTL1
SCHEMBL14363094 0.64 L3MBTL1 (0.50) MEN1KMT2APOLBTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718308-A4 METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY PAINCEPTOR PHARMA CORP (CA) 2007-07-18 EP disclosed
EP-1718308-A2 METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY PainCeptor Pharma Corp. (CA) 2006-11-08 EP disclosed
WO-2005076695-A2 METHODS OF MODULATING NEUROTROPHIN-MEDIATED ACTIVITY PAINCEPTOR PHARMA CORPORATION (CA) 2005-08-25 WO disclosed